Basic Epigenetic Mechanisms in Cancer

Recent advances in technology allow us to consider the epigenome as well as the genome of a tumour on an individual level. These advances, in combination with high throughput technologies, are leading to rapid advances in the development of epigenetic biomarkers and novel therapeutic targets.

 

Termin: 

08.11.2015 -  11.11.2015

 

Veranstaltungsort:

Harnack House - The Conference Centre of the Max Planck Society
Ihnestr. 16-20
14195 Berlin

 

Informationen im Web:

atnd.it/27171-0

Veranstalter:

European Association for Cancer Research
Sir Colin Campbell Building
NG7 2TU Nottingham

Frau Caroline Moulins
Tel.: 004401159515066

E-Mail: caroline.moulins@nottingham.ac.uk